Skip to main content

The Assistance Fund: Chronic Granulomatous Disease (CGD) Financial Assistance

The Assistance Fund

OpenVerified·Apr 24, 2026

The Assistance Fund's Chronic Granulomatous Disease (CGD) program offers financial assistance for copays, coinsurance, deductibles, health insurance premiums, and other medical expenses related to FDA-approved treatments for CGD. This support is for commercially insured or Medicare/Medicaid patients residing in the US and Puerto Rico who are prescribed specific medications and meet financial eligibility criteria.

Covers
financial assistance
Enrollment cycle
annual

Eligibility

Applicants must be residents of the U.S. or Puerto Rico with a primary diagnosis of Chronic Granulomatous Disease and be prescribed specific qualifying medications. This is a needs-based program requiring patients to provide demographic, insurance, and financial information for enrollment.

Apply

Application goes directly to The Assistance Fund. RxCopays does not receive compensation.

Go to application →

Status source

Program offers conditional approval of 30 days of immediate assistance for open programs where funding is available